These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22469829)

  • 1. Twists and turns of invasion.
    Childs G; Segall JE
    Nat Cell Biol; 2012 Apr; 14(4):337-9. PubMed ID: 22469829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAC1 activation mediates Twist1-induced cancer cell migration.
    Yang WH; Lan HY; Huang CH; Tai SK; Tzeng CH; Kao SY; Wu KJ; Hung MC; Yang MH
    Nat Cell Biol; 2012 Mar; 14(4):366-74. PubMed ID: 22407364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour invasion: a new twist on Rac-driven mesenchymal migration.
    Sanz-Moreno V
    Curr Biol; 2012 Jun; 22(11):R449-51. PubMed ID: 22677287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between microRNAs and Twist1 transcription factor: a systematic review.
    Khanbabaei H; Teimoori A; Mohammadi M
    Tumour Biol; 2016 Jun; 37(6):7007-19. PubMed ID: 26880587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation.
    Sun T; Fu J; Shen T; Lin X; Liao L; Feng XH; Xu J
    J Biol Chem; 2016 May; 291(22):11518-28. PubMed ID: 26975371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
    Yang WH; Su YH; Hsu WH; Wang CC; Arbiser JL; Yang MH
    Oncogene; 2016 May; 35(18):2287-98. PubMed ID: 26257063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay.
    Cheng GZ; Zhang W; Wang LH
    Cancer Res; 2008 Feb; 68(4):957-60. PubMed ID: 18281467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TWIST1 in epithelial-mesenchymal transition and cancers.
    Zhu QQ; Ma C; Wang Q; Song Y; Lv T
    Tumour Biol; 2016 Jan; 37(1):185-97. PubMed ID: 26602382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.
    Zhang X; Wei C; Li J; Liu J; Qu J
    Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
    Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J
    J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenesis: Twist1 links EMT to self-renewal.
    Martin A; Cano A
    Nat Cell Biol; 2010 Oct; 12(10):924-5. PubMed ID: 20885418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.